Pernille Gro Thrane retweeted
Per-patient prevalence of high-risk vulnerable plaques was comparable in STEMI vs NSTEMI, as was the overall long-term incidence of non-culprit lesion-related & all MACE. @MichaelMaeng1 @GroThrane @DavidErlinge @GreggWStone @FrobertOle @ziadalinyc ahajournals.org/doi/10.1161/…
Pernille Gro Thrane retweeted
In PROSPECT II, elevated TC, LDL-C, & non-HDL-C were strongly associated w/ pancoronary atherosclerosis & lipid deposition, whereas elevated Lp(a) was strongly associated w/ the presence of focal vulnerable plaques.
Get more details: bit.ly/43lbEMP #JACC @JACCJournals
Pernille Gro Thrane retweeted
📖In over 215,000 pts from the #SCAAR & #WDHR registry, smoking was associated w progressive #CAD in #RCA, & smokers were more likely to receive #PCI vs RCA than #LAD when presenting with #STEMI 💡
Read more:
➡️doi.org/10.1016/j.jscai.2025…
@FrobertOle @GroThrane @GreggWStone @moman_am
Excited to share our findings on 10-year mortality after STEMI, now in @JACCJournals
👉STEMI patients surviving the first 90 days have only mildly elevated mortality compared to a matched general population. doi.org/10.1016/j.jacc.2024.…
@MichaelMaeng1 #STEMI #cardiotwitter
Pernille Gro Thrane retweeted
Over the past decade, proportion of women authors in major CV journals remained low. Call to action is needed to increase equitable opportunities to promote women bit.ly/3Xj9I4X
#JACC #ACCWIC #WomenInCardiology @ridhimagoel547 @Drroxmehran @DeeDeeWangMD @pamelasdouglas
Pernille Gro Thrane retweeted
This study evaluated the safety and efficacy of single antiplatelet therapy (SAPT) after left atrial appendage occlusion (LAAO) with Amplatzer devices in a cohort of 431 high bleeding risk patients. At 6 months, a significant portion of patients had discontinued antithrombotic therapy, yet the incidence of device-related thrombosis (DRT) was low at 1.5%. The 1-year ischaemic stroke rate was 2.2%, with rates of major bleeding and cardiovascular death at 5.9% and 2.9%, respectively. These findings suggest that SAPT is an effective postprocedural strategy for LAAO, efficiently balancing the prevention of DRT against the risk of bleeding. ow.ly/RMoE50QPptl
Read also the Editorial by Mohamad Alkhouli
eurointervention.pcronline.c…
Pernille Gro Thrane retweeted
🌍Real-world implications of #SELECT trial.
31% of patients with #MI are SELECT-eligible to treatment with semaglutide.
Number needed to treat of 49 patients to prevent one MACE.
shorturl.at/movAK
#Obesity #Cardiotwitter @JACCJournals @AUHdk @AarhusUni @MaleneKHansen
Pernille Gro Thrane retweeted
🫀New publication in @JACCJournals by @CGyldenkerne et al.
👩🎓 Young patients with newly diagnosed #type2diabetes have the highest relative risk of #CVD
📷 Indicate an unmet need for optimized prophylactic treatment!
@MichaelMaeng1 @dr_rwt
link: jacc.org/doi/abs/10.1016/j.j…
Pernille Gro Thrane retweeted
🎓In 43,758 individuals, @TanjaCharlotteF et al found that weight gain was associated with higher risk of AF compared to stable weight!
🔦highlighting the importance of weight management for primary prevention of AF.
link: academic.oup.com/eurjpc/adva…
#Cardiotwitter #Epeeps
Pernille Gro Thrane retweeted
👩🎓New publication in @JACCJournals
🧐Is STEMI mortality still declining?
💔Substantial reduction in 1-year mortality after pPCI-treated #STEMI from 2003 to 2018. Largest drop within 30 days, suggesting early optimization
@GroThrane @MichaelMaeng1 @AUHdk
rb.gy/0rg0y
Pernille Gro Thrane retweeted
Patienter med akut blodprop i hjertet, der overlever de første 90 dage, har ingen overdødelighed sammenlignet med den øvrige befolkning, viser dansk undersøgelse præsenteret på #ESCCongress2023 #sundpol
buff.ly/47TncqM
Pernille Gro Thrane retweeted
The BMJ wants to publish the gold not the mould, the frankincense not the makes-no-sense, and the myrrh not the urrgghh.
This list of 12 statistical issues routinely encountered during peer review aims to help authors of future submissions #ChristmasBMJ
bmj.com/content/379/bmj-2022…
Pernille Gro Thrane retweeted
In this episode of @edecmo podcast, @MSivagowry talks about how #eCPR is performed at @AUHdk 🫀🚑🏥
Listen to the podcast here 👇🏻
https://teapaw.org/t.co/cLnGIGHGa6
Pernille Gro Thrane retweeted
Bleeding 🩸 on dual antiplatelet therapy (DAPT) after PCI in pt’s with chronic coronary syndrome was associated with increased risk of death and rebleeding after nine years in this study presented by @GroThrane #ESCCongress 👇🏻
Pernille Gro Thrane retweeted
At #ESCCongress @KrisWarnakula just presented a large study examining wether diabetes remains a cardiovascular risk equivalent to #CHD
@escardio #ESC2022
Watch this clip for the main results 👇🏻
Pernille Gro Thrane retweeted
A HUGE congratulations to Steen Dalby Kristensen for being awarded the #ESC President’s Award - what a great achievement
#esccongress2022 @escardio @cardio_dk
🏆🎖🫀
Pernille Gro Thrane retweeted
Also read the linked Comment by Ibrahim Akin
& Christoph A. Nienaber
"Ticagrelor after Acute Coronary Syndrome: One For All or Part of Personalized Medicine?"
thelancet.com/journals/lanep…
Pernille Gro Thrane retweeted
Ticagrelor was introduced in Denmark in 2011 for patients with acute coronary syndrome (ACS).
This study assessed the effectiveness & safety of ticagrelor implementation in ACS patients undergoing percutaneous coronary intervention
👇🏼
tinyurl.com/mr3u5388
Pernille Gro Thrane retweeted
PhD student @GroThrane presented her study on #Ticagrelor implementation in PCI-treated #ACS patients at #ESCCongress 💊
Watch on demand 👉 cyim.page.link/JCHv
@escardio #CardioTwitter























